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1. Introduction 
Metallothioneins constitute a family of low 
molecular weight proteins (6000-7000) of unusually 
high metal and cysteine content which occur in 
parenchymatous tissues of vertebrates and which are 
most abundant in liver and kidney [l] . 
Depending on the source, they contain variable 
amounts of Zn, Cd and Cu which add up to a stoichio- 
metric ratio of 6 or 7 g-atom metal/m01 [2] . In experi- 
mental animals the formation of metallothionein can 
be induced by the administration of a variety of 
metals (Zn, Cd, Cu, Hg, Ag) and, hence, they have 
been suggested to play a role in metal detoxication 
[3]. However, recent studies have shown that the 
naturally occurring metallothioneins of human liver 
contain zinc as the only significant metallic compo- 
nent thus suggesting that their primary biological 
function is related to the metabolism of this essential 
element [4] . 
All metallothioneins examined thus far are single 
chain proteins of about 60 amino acid residues [5] . 
Besides their high cysteine content they are unusual 
by a total lack of aromatic amino acids and histidine 
(see table 1). In general, each metal ion is bound by 
three cysteinyl residues forming a negatively-charged 
trimercaptide complex [l] . 
In this paper we report the first amino acid sequence 
of a human zinc metallothionein and compare it to 
the known primary structure of equine metallo- 
thionein (MT-1 B) [ 11. 
2. Methods 
Human hepatic metallothionein, type MT-2, was 
isolated by the method of Btihler and Kiigi [4] and 
North-Holland Publishing Company - Amsterdam 
modified by S-pyridylethylation following removal 
of the metal [l] . The N-terminus is blocked but a 
free end group for sequence analysis could be gene- 
rated by selective cleavage of the acid-labile bond, 
between Asp-2 and Pro-3, resulting in the dipeptide 
AP-I and the fragment API1 (see fig.1). These 
fragments were separated by gel filtration on Bio-Gel 
P-2 (Bio-Rad Laboratories, Richmond, Calif.). Two 
other large fragments, SP-I and SP-II, were obtained 
by cleavage of the single glutamyl bond by Staphylo- 
coccus aureus protease (Miles Laboratories, Slough, 
England), at pH 4.0, in ammonium acetate buffer [6] 
and by separation on Sephadex G-25. Sequence 
determination was carried out on an automatic 
sequenator (Beckman, Model 890B, updated) using 
previously applied procedures [l] . The average 
repetitive yield was 92%. The phenylthiohydantoin 
derivatives of the amino acids were identified by gas 
chromatography, by thin-layer chromatography, and 
by amino acid analysis after their conversion to free 
amino acids by hydrolysis in HC1/SnC12 [7] . 
3. Results 
The complete amino acid sequence of human 
hepatic MT-2 is shown in fig.1. The structure of the 
N-terminal peptide AP-I was deduced from compari- 
son with the homologous peptide of equine MT-1B 
and synthetic acetyl-Met-Asp using thin-layer 
chromatography [8] . Residues 3-34 were determined 
on fragment AP-II, residues 24-56 on SP-II. The 
C-terminal sequence from residues 55-61 was estab- 
lished by digestion of the carbamidomethylated 
derivative of MT-2 with carboxypeptidases A and B 
(Worthington) [l] . Further confirmation of the 
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Fig.1. Amino acid sequence determination of human hepatic metallothionein MT-2, AP-I and AP-II, fragments from acid cleavage; 
SP-II, fragment from Staphylococcus aureus protease digestion. Arrows to the right, automated sequence analysis; arrows to the 
left, carboxypeptidase A and B digestion. 
sequence was obtained from supplementary analyses 
of tryptic peptides prepared from the carboxymethyl- 
ated derivative of the protein [9] and from fragments 
obtained by cleavage of a second acid-labile bond 
occurring between Asp-l 1 and Ser-12 on prolonged 
incubation with 70% formic acid. The sequence 
accounts for the amino acid composition reported 
previously (table 1). 
4. Discussion 
The primary structure of the human protein is 
similar to that of equine MT-1B (fig.2). Their most 
characteristic common feature is the identical 
distribution of the 20 cysteinyl residues along the 
chain which provide the principal ligands for metal 
binding. Based on stoichiometric considerations it 
has been suggested that the seven Cys-X-Cys 
sequences constitute the primary chelation sites for 
the seven metal ions bound [l] . Through appropriate 
folding of the polypeptide chain most of these initial 
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dimercaptide complexes are thought to interact with 
one additional cysteinyl side chain to form the 
negatively-charged trimercaptide complexes indicated 
by spectroscopic data [2,10,11]. With the one 
exception of Lys-25 which corresponds to Arg-25 in 
equine MT-lB, the positions of Ser and Lys, the 
next most abundant amino acid residues, are also 
maintained. These residues are located predominantly 
in juxtaposition to cysteine and have been suggested 
to participate also directly or indirectly in metal 
binding [l] . The differences between human MT-2 
and equine MT-1B are limited to six amino acid 
substitutions which can be accounted for by single- 
base changes. With the exception of the Gln-Glu 
replacement in position 23 they can be considered as 
conservative substitutions [ 121 . The degree of identity 
emerging from these data (91.2%) can be compared 
with the corresponding value for cytochrome c 
(88.5%) [ 131 and indicates thus a similarly low rate 
of molecular evolution. The very striking conservation 
of the metal-binding residues in these two orders of 
mammals suggests that the competence of the protein 
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Table 1 
Amino acid compositions of human and equine metallothioneins 
Residue 
Human hepatic 
metallothionein 
(MT-2) 
Number per molecule 
Analysis’ Sequence 
Equine renal 
metallothionein 
(MT-1B) 
Analysis’ Sequence’ 
CYS 
Asx 
Asp 
Asn 
Thr 
Ser 
Glx 
Glu 
Gln 
Pro 
Gly 
Ala 
Val 
Met 
Be 
Lys 
Arg 
20.55 
4.06 
2.08 
8.30 
2.39 
2.07 
5.14 
6.81 
1.12 
0.87 
0.95 
7.78 
_ 
Total 61 61 
Metala 
Zinc 
Cadmium 
7.12 2.55 
0.10 4.61 
Total 7.22 7.16 
20 
- 
20.70 
3.05 
1.09 
7.29 
2.87 
1.80 
5.60 
7.11 
2.74 
0.94 
_ 
6.79 
1.16 
a The content of copper was less than 0.1 atoms per molecule in both proteins 
The molecular weights of the chains (61 residues including the amino-terminal 
acetyl group) calculated from sequence data are 6085 for human MT-2 and 
6110 for equine MT-1B. The corresponding values for the molecular weights 
including 7 metal ions are 6548 and 6780, respectively 
Fig.2. Primary structure of human and equine metallothioneins. Boxes indicate positions of nonidentical amino acid residues. 
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for metal binding is the feature selected for in these 
molecules. 
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